IINN Stock Overview
A specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Inspira Technologies Oxy B.H.N. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.38 |
| 52 Week High | US$2.49 |
| 52 Week Low | US$0.76 |
| Beta | 2.09 |
| 11 Month Change | 2.22% |
| 3 Month Change | 23.21% |
| 1 Year Change | 35.29% |
| 33 Year Change | -54.15% |
| 5 Year Change | n/a |
| Change since IPO | -70.95% |
Recent News & Updates
Shareholder Returns
| IINN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.8% | 1.2% | 2.0% |
| 1Y | 35.3% | 22.6% | 32.4% |
Return vs Industry: IINN exceeded the US Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: IINN exceeded the US Market which returned 32.6% over the past year.
Price Volatility
| IINN volatility | |
|---|---|
| IINN Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: IINN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: IINN's weekly volatility has decreased from 12% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 40 | Dagi Ben-Noon | inspira-technologies.com |
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels.
Inspira Technologies Oxy B.H.N. Ltd. Fundamentals Summary
| IINN fundamental statistics | |
|---|---|
| Market cap | US$25.16m |
| Earnings (TTM) | -US$11.29m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.3x
P/E RatioIs IINN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IINN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$11.29m |
| Earnings | -US$11.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.61 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did IINN perform over the long term?
See historical performance and comparison